Beta Bionics, Inc. (BBNX) vs Cytek Biosciences, Inc. (CTKB)
A side-by-side comparison of Beta Bionics, Inc. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.95HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CTKB
Cytek Biosciences, Inc.
$5.97HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — BBNX vs CTKB
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)CTKB +7.6% (+3.7%/yr)CTKB compounded faster over this window
BBNX CTKB
BBNX vs CTKB: by the numbers
- •BBNX is the larger company ($852M vs $770M market cap).
- •Both run net losses; CTKB's is the smaller (-38.98% vs -61.32% net margin).
Metrics side by side
Valuation
| Metric | BBNX | CTKB |
|---|---|---|
| P/S ratio | 7.16 | 3.73 |
| P/B ratio | 3.33 | 2.39 |
Profitability
| Metric | BBNX | CTKB |
|---|---|---|
| Gross margin | 58.31% | 53.23% |
| Operating margin | -69.75% | -21.60% |
| Net margin | -61.32% | -38.98% |
| ROE | -28.46% | -25.03% |
| ROIC | -31.17% | -12.00% |
Growth (annualized)
| Metric | BBNX | CTKB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.37% |
| Total return CAGR (5Y) | N/A | -23.16% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.